packageAmifampridine

amifampridine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Amifampridine is a potassium channel blocker used to treat Lambert-Eaton myasthenic syndrome and myasthenia gravis. It is approved and authorised in the European Union, where two products are on the market.

Summary written by glm-5.3-flash from Wikidata Q411707 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:amifampridine
ATC codes:N07XX05
DrugBank:DB11640
PubChem CID:5918
ChEBI:135948
Wikidata:Q411707
formula:C5H7N3
molar mass:109.132 g/mol (PubChem CID 5918)
logP:-0.5 (Drugs.Common 25.09, not verified)

Metabolites

NAcetyl34Diaminopyridine3AcDAP33-N-acetyl-3,4-diaminopyridine (3-Ac DAP)151.169 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
NAcetyl34Diaminopyridine3AcDAP3metabolite: 3-N-acetyl-3,4-diaminopyridine (3-Ac DAP)